Terms: = Cervical cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Diagnosis
5 results:
1. Primary ewing sarcoma in the uterine cervix with multiple bone metastases.
Jia P; Cui R; Zhang Y
Arch Gynecol Obstet; 2022 Sep; 306(3):911-912. PubMed ID: 35665855
[TBL] [Abstract] [Full Text] [Related]
2. cervical cytological screening: Assessment of the Fournier ® self-sampling device in a cervical pathology outpatient clinic.
da Silva Rocha A; Guilherme Schaefer P; Isabel Albano Edelweiss M
Diagn Cytopathol; 2015 Oct; 43(10):802-9. PubMed ID: 26223029
[TBL] [Abstract] [Full Text] [Related]
3. Forkhead box protein P1 is a useful marker for the diagnosis of mucinous minimal deviation adenocarcinoma of uterine cervix.
Yang Q; Jiang W; Li L; Huang Q; Yang KX
Ann Diagn Pathol; 2014 Aug; 18(4):232-7. PubMed ID: 24908370
[TBL] [Abstract] [Full Text] [Related]
4. Association of the IGF-I promoter P1 polymorphism with risk of cervical cancer.
Pacholska-Bogalska J; Józefiak A; Nowak W; Kedzia W; Kwaśniewska A; Goździcka-Józefiak A
Eur J Gynaecol Oncol; 2011; 32(4):393-8. PubMed ID: 21941959
[TBL] [Abstract] [Full Text] [Related]
5. Antibody anti-p16(INK4a) in cervical cytology.
Rocha AS; Bozzetti MC; Kirschnick LS; Edelweiss MI
Acta Cytol; 2009; 53(3):253-62. PubMed ID: 19534263
[TBL] [Abstract] [Full Text] [Related]
